Rene Russo insider trades
Open-market stock purchases and sales by Rene Russo, PRESIDENT AND CEO at Xilio Therapeutics, Inc, from SEC Form 4 filings since Mar 7, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 1, 2026 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Dec 31, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $1.4M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $150K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $1.9M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $225K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $942K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $525K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $1.9M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $1.1M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | — |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $1.3M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $360K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $2.8M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $710K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $1.6M |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $203K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Sold (not open market) | $801K |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc | Bought (not open market) | $75.1K |